Sixth JCA-AACR Special Joint Conference on the Latest Advances in Lung Cancer Research: From Basic Science to Therapeutics

July 10-12, 2018
Kyoto Tokyu Hotel
Kyoto, Japan

Abstract Submission Deadline: Tuesday, April 10, 2018
Registration Deadline: Friday, June 8, 2018

Organizing Committee

Hiroyuki Mano
, National Cancer Center, Tokyo, Japan
Seiji Yano, Kanazawa University, Kanazawa, Japan
Hiroyoshi Nishikawa, National Cancer Center, Tokyo, Japan

Alice T. Shaw
, Massachusetts General Hospital Cancer Center, Boston, Massachusetts
Roy S. Herbst, Yale Cancer Center, New Haven, Connecticut
Charles M. Rudin, Memorial Sloan Kettering Cancer Center, New York, New York

Topics to include:

  • Personalized treatment strategies in lung cancer
  • Latest advances in small cell lung cancer and mesothelioma
  • Targeting KRAS-mutant lung cancer
  • Overcoming resistance to targeted therapies in lung cancer
  • Novel immunotherapy strategies: Beyond PD-1/PD-L1
  • Primary and acquired mechanisms of resistance to immunotherapies
  • Tumor heterogeneity and circulating tumor DNA
  • Tumor microenvironment and implications for treatment